Avalo Therapeutics (AVTX) Preferred Shares (2017 - 2021)

Avalo Therapeutics (AVTX) has 5 years of Preferred Shares data on file, last reported at $1000.0 in Q1 2021.

• Quarterly Preferred Shares fell 20.45% year-over-year to $1000.0 in Q1 2021, while the trailing twelve-month figure through Mar 2021 was $1000.0 (down 20.45% YoY) and the FY2020 annual result came in at $1000.0, down 65.0% from the prior year.
• Preferred Shares held at $1000.0 in Q1 2021, from $1000.0 in the prior quarter.
• In the past five years, Preferred Shares ranged from a high of $2857.0 in Q4 2018 to a low of $4.0 in Q1 2017.
• A 5-year average of $1672.0 and a median of $1257.0 in 2020 frame the typical range for Preferred Shares.
• Annual changes were most pronounced in 2019 — Preferred Shares changed 0.0% — and 2020, when it tumbled 65.0%.
• Tracing AVTX's Preferred Shares over 5 years: stood at $4.0 in 2017, then jumped by 71325.0% to $2857.0 in 2018, then changed by 0.0% to $2857.0 in 2019, then tumbled by 65.0% to $1000.0 in 2020, then changed by 0.0% to $1000.0 in 2021.
• The last three Preferred Shares figures came in at $1000.0 (Q1 2021), $1000.0 (Q4 2020), and $1257.0 (Q3 2020), per Business Quant data.